SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
| Status: | Completed |
|---|---|
| Conditions: | Chronic Obstructive Pulmonary Disease, Other Indications, Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases, Other |
| Healthy: | No |
| Age Range: | 50 - Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2008 |
| End Date: | October 2009 |
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
To evaluate SUN11031 for injection compared to placebo in subjects with cachexia associated
with Chronic Obstructive Pulmonary Disease (COPD) to determine the effect on physical
performance and body composition.
with Chronic Obstructive Pulmonary Disease (COPD) to determine the effect on physical
performance and body composition.
Inclusion Criteria:
- Male or non-pregnant female subjects ≥50 years of age with a clinical diagnosis of
COPD
- Loss >5% of subject's usual body weight
Exclusion Criteria:
- Severe anemia (hemoglobin ≤8 g/dL)
- COPD exacerbation
- Currently undergoing treatment or evaluation for cancer
- Type I or type II diabetes mellitus or a fasting serum glucose of ≥115 mg/dL
We found this trial at
12
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials